Price target
64.750.000.00%
The 8 analysts offering 1 year price forecasts for HALO have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to HALO in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
HALO EPS for the last quarter is 1.27 USD despite the estimation of 0.99 USD. In the next quarter EPS is expected to reach 1.16 USD. Track more of Halozyme Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Halozyme Therapeutics, Inc. revenue is expected to reach 285.74 M USD. Check out Halozyme Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, HALO price target is 64.75 USD with a max estimate of 77.00 USD and a min estimate of 53.00 USD. Check if this forecast comes true in a year, meanwhile watch Halozyme Therapeutics, Inc. stock price chart and keep track of the current situation with HALO news and stock market news.
We've gathered opinions of 9 analysts rating HALO stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.